Multimodal ultrasound muscle assessment in patients with rheumatic diseases: a patient-based reliability study
Gianluca Smerilli,Erica Moscioni,Roberta Sclocco,Maria Giovanna Lommano,Edoardo Cipolletta,Vincenzo Maccarrone,Sonia Farah,Rossella De Angelis,Fausto Salaffi,Walter Grassi,Emilio Filippucci,Andrea Di Matteo
DOI: https://doi.org/10.1093/rap/rkad072
2023-08-18
Rheumatology Advances in Practice
Abstract:Abstract Objectives To explore the inter-reliability of a newly developed ultrasound (US) scanning protocol (“multimodal US”) for the assessment of different aspects of sarcopenia-related muscle involvement including muscle mass, muscle quality and muscle stiffness [using point shear-wave elastography (SWE)], in patients with rheumatic and musculoskeletal diseases (RMDs). Methods Quadriceps muscle mass (i.e. muscle thickness), muscle quality (i.e. muscle echogenicity evaluated both with visual a semi-quantitative scale and a dedicated software for image analysis, ImageJ) and point SWE measurements were obtained by two rheumatologists (blinded to each other’s evaluation) in consecutive RMD patients without previous/current myositis or neuromuscular disorders. Inter-reliability was assessed using intraclass correlation coefficient (ICC) for continuous variables and Cohen’s Kappa (k) for categorical variables. Results A total of 45 RMDs patients were enrolled (mean age 54.5 ± 16.0, male/female ratio 1:1.5, mean BMI 24.6 ± 4.6), 10 with psoriatic arthritis, 7 rheumatoid arthritis, 5 ankylosing spondylitis, 5 polymyalgia rheumatica, 4 systemic lupus erythematosus, 4 gout, 4 osteoarthritis, 3 fibromyalgia, 3 systemic sclerosis. The grade of inter-rater reliability was excellent for muscle mass [ICC=0.969 (0.953<ICC<0.979)]. Regarding muscle echogenicity, the agreement was substantial/almost perfect using the visual semi-quantitative scale (weighted linear=0.793, weighted squared=0.878) and excellent using ImageJ analysis [ICC=0.916 (0.876<ICC<0.944)]. Finally, a good agreement was obtained for point SWE measurements [ICC=0.76 (0.712<ICC<0.8)]. Conclusion Multimodal US is a novel and reliable tool for the evaluation of different aspects of muscle involvement (muscle mass, muscle quality and muscle stiffness) in RMD patients. Lay summary What does this mean for patients ? Sarcopenia is a muscle disease, which is characterized by a progressive and generalized reduction of muscle mass and muscle strength. Sarcopenia has been associated with an increased likelihood of adverse outcomes, including falls, hospitalization and death. Sarcopenia is typically an age-related disease (“primary sarcopenia”). However, it can also occur in younger patients with rheumatic and musculoskeletal diseases (RMDs), due to reduced mobility, chronic inflammation, and use of corticosteroids (“secondary sarcopenia”). An early diagnosis of sarcopenia and prompt interventions, including physical exercise, might potentially improve the long-term outcomes of patients affected by this condition. With the current study, we aimed to test the reliability of a recently developed ultrasound scanning protocol for the assessment of different elements of sarcopenia-related muscle involvement, such as muscle mass, muscle quality and muscle stiffness. As shown in a previous study of our research group, this scanning protocol has the potential to identify ‘early’ muscle involvement in RMD patients, thus emerging as a potential tool for the early identification of sarcopenia-related muscle involvement in these patients. The results of the current study bring new evidence supporting the reliability of this newly developed scanning protocol for the assessment of sarcopenia-related muscle involvement in patients with RMDs.